ISPOR - EE518 Economic Evaluations of Anifrolumab for the Management of Patients Affected by Systemic Lupus Erythematosus (SLE) in Italy

Full Text

EE518 Economic Evaluations of Anifrolumab for the Management of Patients Affected by Systemic Lupus Erythematosus (SLE) in Italy

Abstract

Authors

A Fortunato E Di Brino F Rumi M Basile D Antonini G Falasca S Di Pippo

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now